Home > Insider Trading > Filing (0001209191-14-076841)

Filing Details

Accession Number:: 0001209191-14-076841
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-18 20:55:33
Reporting Period:: 2014-12-16

Filing Date:: 2014-12-18
Accepted Time:: 2014-12-18 20:55:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
858803	Avanir Pharmaceuticals Inc.	AVNR	Pharmaceutical Preparations (2834)	330314804

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1280154	Christine Ocampo	30 Enterprise Suite 400 Aliso Viejo CA 92656	Vice President, Finance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-12-16	12,500	$2.59	127,077	No	4	M	Direct
Common Stock	Acquisiton	2014-12-16	17,500	$4.18	144,577	No	4	M	Direct
Common Stock	Disposition	2014-12-16	12,500	$16.94	132,077	No	4	S	Direct
Common Stock	Disposition	2014-12-16	17,500	$16.94	114,577	No	4	S	Direct
Common Stock	Disposition	2014-12-18	5,780	$16.93	108,797	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-12-16	12,500	$0.00	12,500	$2.59
Common Stock	Stock Option (Right to Buy)	Disposition	2014-12-16	17,500	$0.00	17,500	$4.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
17,500		2022-12-17	No	4	M	Direct
0		2020-12-01	No	4	M	Direct

Footnotes

Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. A majority of the proceeds from the sales will be used to pay required withholdings due by the Reporting Person for vesting RSUs.
Represents the weighted-average price at which shares were sold within a range between $16.92 and $16.95. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Represents the weighted-average price at which shares were sold within a range between $16.93 and $16.95. The reporting persons hereby undertake to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option was granted on 12/17/2012 and vested with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares quarterly thereafter over the next three years.
The option was granted on 12/1/2010 and vested with respect to one-quarter of the underlying shares upon the first anniversary of the grant date, and then with respect to the remaining shares quarterly thereafter over the next three years.